Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55.2M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
27.7M
-
Shares change
-
-1.77M
-
Total reported value, excl. options
-
$296M
-
Value change
-
-$21.2M
-
Number of buys
-
36
-
Number of sells
-
-54
-
Price
-
$10.67
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q3 2020
123 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q3 2020.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.7M shares
of 55.2M outstanding shares and own 50.24% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (6.39M shares), Bellevue Group AG (2.71M shares), ARMISTICE CAPITAL, LLC (2.7M shares), BlackRock Inc. (2.58M shares), VANGUARD GROUP INC (2.25M shares), Clearbridge Investments, LLC (1.39M shares), Bank of New York Mellon Corp (1.14M shares), CITADEL ADVISORS LLC (839K shares), RENAISSANCE TECHNOLOGIES LLC (826K shares), and STATE STREET CORP (567K shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.